Scientists identify molecules associated with recurrence in blood samples from malaria patients.

A recent study conducted by Brazilian researchers has identified possible biomarkers associated with the recurrence of vivax malaria, the most common type of malaria in Brazil. The ability of the parasite Plasmodium vivax to produce dormant forms in the host's liver that can be reactivated months after treatment makes it difficult to control. The study analyzed blood plasma samples from 110 patients and found that patients with recurrent malaria exhibited modulation in lipid pathways involved in the host's immune system. The researchers hope that these findings will contribute to the development of antimalarial drugs and better understanding of recurrence. [Extracted from the article]